富蘭克林坦伯頓全球投資系列-生技領航基金美元A(acc)股
39.35美元0.5(1.29%)
2024/04/23更新
績效 / 1月8.89%
3月1.04%
1年11.93%
晨星評等 - 1.現金0.89%
- 2.股票13.01%
- 3.債券0.00%
- 4.其他86.10%
- 1.美國85.18%
- 2.歐洲不包含歐元區4.22%
- 3.英國3.89%
- 4.歐元區3.88%
- 5.加拿大0.98%
- 1.Amgen Inc6.85%
- 2.Regeneron Pharmaceuticals Inc6.43%
- 3.Vertex Pharmaceuticals Inc5.34%
- 4.Ascendis Pharma A/S ADR4.22%
- 5.Gilead Sciences Inc3.07%
- 6.AstraZeneca PLC ADR3.01%
- 7.Biogen Inc2.88%
- 8.Applied Therapeutics Inc2.71%
- 9.Jazz Pharmaceuticals PLC2.67%
- 10.Intra-Cellular Therapies Inc2.62%
- 1.現金0.89%
- 2.股票13.01%
- 3.債券0.00%
- 4.其他86.10%
- 1.美國85.18%
- 2.歐洲不包含歐元區4.22%
- 3.英國3.89%
- 4.歐元區3.88%
- 5.加拿大0.98%
- 1.Amgen Inc6.85%
- 2.Regeneron Pharmaceuticals Inc6.43%
- 3.Vertex Pharmaceuticals Inc5.34%
- 4.Ascendis Pharma A/S ADR4.22%
- 5.Gilead Sciences Inc3.07%
- 6.AstraZeneca PLC ADR3.01%
- 7.Biogen Inc2.88%
- 8.Applied Therapeutics Inc2.71%
- 9.Jazz Pharmaceuticals PLC2.67%
- 10.Intra-Cellular Therapies Inc2.62%